MXPA01001609A - Method for producing plants with increased flavonoid and phenolic compound content - Google Patents
Method for producing plants with increased flavonoid and phenolic compound contentInfo
- Publication number
- MXPA01001609A MXPA01001609A MXPA/A/2001/001609A MXPA01001609A MXPA01001609A MX PA01001609 A MXPA01001609 A MX PA01001609A MX PA01001609 A MXPA01001609 A MX PA01001609A MX PA01001609 A MXPA01001609 A MX PA01001609A
- Authority
- MX
- Mexico
- Prior art keywords
- plants
- plant
- hydroxylase
- enzymatic
- flavanone
- Prior art date
Links
- 150000002215 flavonoids Chemical class 0.000 title claims abstract description 28
- 229930003935 flavonoids Natural products 0.000 title claims abstract description 28
- 230000001965 increased Effects 0.000 title claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 235000021285 flavonoid Nutrition 0.000 title abstract description 10
- 150000002989 phenols Chemical class 0.000 title description 9
- 230000000694 effects Effects 0.000 claims abstract description 23
- 230000002068 genetic Effects 0.000 claims abstract description 4
- 241000196324 Embryophyta Species 0.000 claims description 49
- 108010018087 flavanone 3-dioxygenase Proteins 0.000 claims description 30
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 25
- 235000017173 flavonoids Nutrition 0.000 claims description 18
- 230000000692 anti-sense Effects 0.000 claims description 16
- 235000013824 polyphenols Nutrition 0.000 claims description 16
- 230000002255 enzymatic Effects 0.000 claims description 14
- 230000014509 gene expression Effects 0.000 claims description 12
- 230000002401 inhibitory effect Effects 0.000 claims description 12
- 239000000470 constituent Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 9
- 244000269722 Thea sinensis Species 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 9
- 235000013616 tea Nutrition 0.000 claims description 8
- 230000036541 health Effects 0.000 claims description 7
- 235000011981 flavanones Nutrition 0.000 claims description 5
- 229930003949 flavanones Natural products 0.000 claims description 5
- 229960000716 TONICS Drugs 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000000855 fermentation Methods 0.000 claims description 4
- 230000004151 fermentation Effects 0.000 claims description 4
- 230000001256 tonic Effects 0.000 claims description 4
- 235000015961 tonic Nutrition 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 3
- 102000004965 antibodies Human genes 0.000 claims description 3
- 108090001123 antibodies Proteins 0.000 claims description 3
- 235000020971 citrus fruits Nutrition 0.000 claims description 3
- 239000002537 cosmetic Substances 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 3
- ZONYXWQDUYMKFB-UHFFFAOYSA-N flavanone Chemical compound O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 claims description 3
- 239000003112 inhibitor Substances 0.000 claims description 3
- 230000001737 promoting Effects 0.000 claims description 3
- 240000002840 Allium cepa Species 0.000 claims description 2
- 240000002234 Allium sativum Species 0.000 claims description 2
- 240000007087 Apium graveolens Species 0.000 claims description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 claims description 2
- 235000010591 Appio Nutrition 0.000 claims description 2
- 240000005662 Aronia melanocarpa Species 0.000 claims description 2
- 235000007425 Aronia melanocarpa Nutrition 0.000 claims description 2
- 235000007319 Avena orientalis Nutrition 0.000 claims description 2
- 244000075850 Avena orientalis Species 0.000 claims description 2
- 240000007124 Brassica oleracea Species 0.000 claims description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 2
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 2
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims description 2
- 235000004221 Brassica oleracea var gemmifera Nutrition 0.000 claims description 2
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 2
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims description 2
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 2
- 240000006906 Brassica oleracea var. capitata Species 0.000 claims description 2
- 240000004448 Brassica oleracea var. gemmifera Species 0.000 claims description 2
- 240000006432 Carica papaya Species 0.000 claims description 2
- 235000009467 Carica papaya Nutrition 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- 240000007154 Coffea arabica Species 0.000 claims description 2
- 240000002860 Daucus carota Species 0.000 claims description 2
- 235000002767 Daucus carota Nutrition 0.000 claims description 2
- 240000001441 Fragaria vesca Species 0.000 claims description 2
- 240000002883 Ginkgo biloba Species 0.000 claims description 2
- 240000007842 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 2
- 240000006600 Humulus lupulus Species 0.000 claims description 2
- 240000009164 Petroselinum crispum Species 0.000 claims description 2
- 240000002799 Prunus avium Species 0.000 claims description 2
- 235000010829 Prunus spinosa Nutrition 0.000 claims description 2
- 240000004350 Prunus spinosa Species 0.000 claims description 2
- 235000007238 Secale cereale Nutrition 0.000 claims description 2
- 240000002057 Secale cereale Species 0.000 claims description 2
- 240000000280 Theobroma cacao Species 0.000 claims description 2
- 240000008529 Triticum aestivum Species 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- 235000002354 carica papaya Nutrition 0.000 claims description 2
- 235000019693 cherries Nutrition 0.000 claims description 2
- 235000016213 coffee Nutrition 0.000 claims description 2
- 235000013353 coffee beverage Nutrition 0.000 claims description 2
- 235000004611 garlic Nutrition 0.000 claims description 2
- 235000002732 oignon Nutrition 0.000 claims description 2
- 235000011197 perejil Nutrition 0.000 claims description 2
- 235000021018 plums Nutrition 0.000 claims description 2
- 235000021012 strawberries Nutrition 0.000 claims description 2
- 235000021307 wheat Nutrition 0.000 claims description 2
- 235000008100 Ginkgo biloba Nutrition 0.000 claims 1
- 244000276497 Lycopersicon esculentum Species 0.000 claims 1
- 235000005764 cacao Nutrition 0.000 claims 1
- 235000005767 cacao Nutrition 0.000 claims 1
- 235000001046 cacaotero Nutrition 0.000 claims 1
- 235000000381 ginkgo Nutrition 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 abstract description 7
- 108090000790 Enzymes Proteins 0.000 abstract description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N (3β)-Cholest-5-en-3-ol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 229920002676 Complementary DNA Polymers 0.000 description 14
- 239000002299 complementary DNA Substances 0.000 description 14
- 240000003768 Solanum lycopersicum Species 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 13
- 239000000126 substance Substances 0.000 description 13
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Resveratrol Natural products C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 10
- 239000003963 antioxidant agent Substances 0.000 description 9
- 235000006708 antioxidants Nutrition 0.000 description 9
- 210000004027 cells Anatomy 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229940107161 Cholesterol Drugs 0.000 description 8
- 230000003078 antioxidant Effects 0.000 description 8
- 201000011510 cancer Diseases 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000002609 media Substances 0.000 description 8
- 210000003494 Hepatocytes Anatomy 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 230000037348 biosynthesis Effects 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 230000002194 synthesizing Effects 0.000 description 6
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 5
- 102000003923 Protein Kinase C Human genes 0.000 description 5
- 108090000315 Protein Kinase C Proteins 0.000 description 5
- 102000004022 Protein-Tyrosine Kinases Human genes 0.000 description 5
- 108090000412 Protein-Tyrosine Kinases Proteins 0.000 description 5
- 235000002560 Solanum lycopersicum Nutrition 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
- NLKUPINTOLSSLD-UHFFFAOYSA-L calcium;4-(1-oxidopropylidene)-3,5-dioxocyclohexane-1-carboxylate Chemical compound [Ca+2].CCC([O-])=C1C(=O)CC(C([O-])=O)CC1=O NLKUPINTOLSSLD-UHFFFAOYSA-L 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000021283 resveratrol Nutrition 0.000 description 5
- 229940016667 resveratrol Drugs 0.000 description 5
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 4
- 241000701489 Cauliflower mosaic virus Species 0.000 description 4
- VEVZSMAEJFVWIL-UHFFFAOYSA-O Cyanidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 description 4
- 108010066133 EC 1.5.1.11 Proteins 0.000 description 4
- 210000002889 Endothelial Cells Anatomy 0.000 description 4
- SBHXYTNGIZCORC-ZDUSSCGKSA-N Eriodictyol Chemical compound C1([C@@H]2CC(=O)C3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 SBHXYTNGIZCORC-ZDUSSCGKSA-N 0.000 description 4
- 230000036740 Metabolism Effects 0.000 description 4
- 229930016253 catechin Natural products 0.000 description 4
- 235000005487 catechin Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000009569 green tea Nutrition 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000035786 metabolism Effects 0.000 description 4
- 230000000051 modifying Effects 0.000 description 4
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000001519 tissues Anatomy 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 240000000239 Camellia sinensis Species 0.000 description 3
- 208000008787 Cardiovascular Disease Diseases 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N Catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- 229940100626 Catechin Drugs 0.000 description 3
- 229950001002 Cianidanol Drugs 0.000 description 3
- FFYPMLJYZAEMQB-UHFFFAOYSA-N Diethylpyrocarbonate Chemical compound CCOC(=O)OC(=O)OCC FFYPMLJYZAEMQB-UHFFFAOYSA-N 0.000 description 3
- 229940110715 ENZYMES FOR TREATMENT OF WOUNDS AND ULCERS Drugs 0.000 description 3
- 229940088598 Enzyme Drugs 0.000 description 3
- 108020004999 Messenger RNA Proteins 0.000 description 3
- 229920000272 Oligonucleotide Polymers 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 3
- 150000001413 amino acids Chemical group 0.000 description 3
- 235000005513 chalcones Nutrition 0.000 description 3
- 229930016212 chalcones Natural products 0.000 description 3
- 230000002113 chemopreventative Effects 0.000 description 3
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 3
- 230000037213 diet Effects 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 239000004459 forage Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000001963 growth media Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 229920002106 messenger RNA Polymers 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 230000019491 signal transduction Effects 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 150000001629 stilbenes Chemical class 0.000 description 3
- 235000021286 stilbenes Nutrition 0.000 description 3
- RVKCCVTVZORVGD-UHFFFAOYSA-N trinexapac-ethyl Chemical group O=C1CC(C(=O)OCC)CC(=O)C1=C(O)C1CC1 RVKCCVTVZORVGD-UHFFFAOYSA-N 0.000 description 3
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- HLVQZEMFVYGIGH-UHFFFAOYSA-L 4-(1-oxidopropylidene)-3,5-dioxocyclohexane-1-carboxylate Chemical compound CCC([O-])=C1C(=O)CC(C([O-])=O)CC1=O HLVQZEMFVYGIGH-UHFFFAOYSA-L 0.000 description 2
- 208000004981 Coronary Disease Diseases 0.000 description 2
- ZIUSSTSXXLLKKK-HWUZOJPISA-N Curcumin Natural products C1=C(O)C(OC)=CC(\C=C\C(\O)=C/C(=O)/C=C/C=2C=C(OC)C(O)=CC=2)=C1 ZIUSSTSXXLLKKK-HWUZOJPISA-N 0.000 description 2
- 229940104302 Cytosine Drugs 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N Cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 241000588694 Erwinia amylovora Species 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N Eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N Ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- -1 Flavonoides polyphenols Chemical class 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N Gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229940068052 Ginkgo biloba extract Drugs 0.000 description 2
- 239000009429 Ginkgo biloba extract Substances 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 102100004115 ICAM1 Human genes 0.000 description 2
- 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N Kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- FSYDWKPCKNCRDI-STQMWFEESA-N Luteoforol Natural products O[C@@H]1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)cc2)C1 FSYDWKPCKNCRDI-STQMWFEESA-N 0.000 description 2
- 210000002540 Macrophages Anatomy 0.000 description 2
- 240000007119 Malus pumila Species 0.000 description 2
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 2
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 2
- 208000010125 Myocardial Infarction Diseases 0.000 description 2
- 102000003945 NF-kappa B Human genes 0.000 description 2
- 108010057466 NF-kappa B Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000008962 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- NGSWKAQJJWESNS-ZZXKWVIFSA-N P-Coumaric acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 description 2
- 240000007377 Petunia x hybrida Species 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N Salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 Serum Anatomy 0.000 description 2
- PCMORTLOPMLEFB-ONEGZZNKSA-N Sinapic acid Natural products COC1=CC(\C=C\C(O)=O)=CC(OC)=C1O PCMORTLOPMLEFB-ONEGZZNKSA-N 0.000 description 2
- 102100009534 TNF Human genes 0.000 description 2
- 235000006468 Thea sinensis Nutrition 0.000 description 2
- 102100019577 VCAM1 Human genes 0.000 description 2
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 230000000111 anti-oxidant Effects 0.000 description 2
- 230000003115 biocidal Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N caffeic acid Natural products OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 230000024881 catalytic activity Effects 0.000 description 2
- 150000001789 chalcones Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 201000008739 coronary artery disease Diseases 0.000 description 2
- 235000007336 cyanidin Nutrition 0.000 description 2
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drugs Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000011797 eriodictyol Nutrition 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- 125000004387 flavanoid group Chemical group 0.000 description 2
- 150000002208 flavanones Chemical class 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- 239000007954 growth retardant Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 150000002516 isoflavones Chemical class 0.000 description 2
- 229930012948 isoflavones Natural products 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- GWCPBEMISACTHQ-AWEZNQCLSA-N luteoliflavan Chemical compound C1([C@@H]2CCC3=C(O)C=C(C=C3O2)O)=CC=C(O)C(O)=C1 GWCPBEMISACTHQ-AWEZNQCLSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L mgso4 Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000006870 ms-medium Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000032361 posttranscriptional gene silencing Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000000021 stimulant Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000004114 suspension culture Methods 0.000 description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N α-Ketoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 description 2
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 1
- 235000004911 (-)-epigallocatechin gallate Nutrition 0.000 description 1
- TYEYBOSBBBHJIV-UHFFFAOYSA-M 2-oxobutanoate Chemical compound CCC(=O)C([O-])=O TYEYBOSBBBHJIV-UHFFFAOYSA-M 0.000 description 1
- YTAQZPGBTPDBPW-UHFFFAOYSA-N 2-phenylchromene-3,4-dione Chemical compound O1C2=CC=CC=C2C(=O)C(=O)C1C1=CC=CC=C1 YTAQZPGBTPDBPW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- 101710025088 66 Proteins 0.000 description 1
- ZSLZBFCDCINBPY-ZSJPKINUSA-N Acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 1
- ZSLZBFCDCINBPY-ZZSFXRQLSA-N Acetyl-CoA Natural products S(C(=O)C)CCNC(=O)CCNC(=O)[C@H](O)C(CO[P@@](=O)(O[P@](=O)(OC[C@@H]1[C@@H](OP(=O)(O)O)[C@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C ZSLZBFCDCINBPY-ZZSFXRQLSA-N 0.000 description 1
- 206010059512 Apoptosis Diseases 0.000 description 1
- 241000287523 Ara Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 101700024634 CDK16 Proteins 0.000 description 1
- 241000252254 Catostomidae Species 0.000 description 1
- 229940074393 Chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N Chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000020504 Collagenase family Human genes 0.000 description 1
- 108060005980 Collagenase family Proteins 0.000 description 1
- 229940109262 Curcumin Drugs 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 206010054044 Diabetic microangiopathy Diseases 0.000 description 1
- 102000016680 Dioxygenases Human genes 0.000 description 1
- 108010028143 Dioxygenases Proteins 0.000 description 1
- 238000004435 EPR spectroscopy Methods 0.000 description 1
- 101700036757 ERN1 Proteins 0.000 description 1
- 102100016655 ERN1 Human genes 0.000 description 1
- 101700014948 ERN2 Proteins 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N Epicatechin gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- 229960002217 Eugenol Drugs 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229940074391 Gallic acid Drugs 0.000 description 1
- 229940045109 Genistein Drugs 0.000 description 1
- ZCOLJUOHXJRHDI-CMWLGVBASA-N Genistin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 ZCOLJUOHXJRHDI-CMWLGVBASA-N 0.000 description 1
- 101700085586 IRE1A Proteins 0.000 description 1
- 101700019719 IRE1B Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 229940047122 Interleukins Drugs 0.000 description 1
- 241000764238 Isis Species 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N Isoamyl alcohol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- 108010001831 LDL receptors Proteins 0.000 description 1
- 102100012475 LDLR Human genes 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 210000004185 Liver Anatomy 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 210000004698 Lymphocytes Anatomy 0.000 description 1
- 108091007472 MAP kinase family Proteins 0.000 description 1
- 101710007526 MAP3K14 Proteins 0.000 description 1
- 240000001047 Malus domestica Species 0.000 description 1
- 102000004331 Mitogen-Activated Protein Kinases Human genes 0.000 description 1
- 108090000823 Mitogen-Activated Protein Kinases Proteins 0.000 description 1
- 101710043199 PIWIL2 Proteins 0.000 description 1
- 102100012174 PIWIL2 Human genes 0.000 description 1
- 101700044505 PUB33 Proteins 0.000 description 1
- 101700045570 PUB34 Proteins 0.000 description 1
- 101700046887 PUB35 Proteins 0.000 description 1
- 101700066160 PUB51 Proteins 0.000 description 1
- 101700067511 PUB52 Proteins 0.000 description 1
- 101700068819 PUB53 Proteins 0.000 description 1
- 101700086326 PUB70 Proteins 0.000 description 1
- 108050005377 Phosphatidylinositol kinase Proteins 0.000 description 1
- 102000017343 Phosphatidylinositol kinase Human genes 0.000 description 1
- HSTZMXCBWJGKHG-CUYWLFDKSA-N Piceid Polymers O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 HSTZMXCBWJGKHG-CUYWLFDKSA-N 0.000 description 1
- 210000002381 Plasma Anatomy 0.000 description 1
- 240000007742 Raphanus sativus Species 0.000 description 1
- 229920001785 Response element Polymers 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N Silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N Sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 description 1
- 241001672648 Vieira Species 0.000 description 1
- 229940046009 Vitamin E Drugs 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 229940121369 angiogenesis inhibitors Drugs 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 229930014669 anthocyanidins Natural products 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000118 anti-eoplastic Effects 0.000 description 1
- 230000001028 anti-proliferant Effects 0.000 description 1
- 230000000259 anti-tumor Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000000923 atherogenic Effects 0.000 description 1
- 201000001320 atherosclerosis Diseases 0.000 description 1
- 230000001580 bacterial Effects 0.000 description 1
- 230000001164 bioregulatory Effects 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 125000004432 carbon atoms Chemical group C* 0.000 description 1
- 201000011529 cardiovascular cancer Diseases 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001889 chemoattractant Effects 0.000 description 1
- 239000002975 chemoattractant Substances 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960005188 collagen Drugs 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000000875 corresponding Effects 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 230000001472 cytotoxic Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000001278 effect on cholesterol Effects 0.000 description 1
- 230000000464 effect on transcription Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003944 flavones Natural products 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- TZBJGXHYKVUXJN-UHFFFAOYSA-N genistein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC(O)=C2C1=O TZBJGXHYKVUXJN-UHFFFAOYSA-N 0.000 description 1
- 235000006539 genistein Nutrition 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000003630 growth substance Substances 0.000 description 1
- 101700073673 gsp-2 Proteins 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 description 1
- 235000010359 hydroxycinnamic acids Nutrition 0.000 description 1
- 229930005346 hydroxycinnamic acids Natural products 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 200000000018 inflammatory disease Diseases 0.000 description 1
- 230000003834 intracellular Effects 0.000 description 1
- 101700052395 ire-1 Proteins 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 229930013686 lignans Natural products 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000001404 mediated Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 210000000663 muscle cells Anatomy 0.000 description 1
- 239000005445 natural product Substances 0.000 description 1
- 229930014626 natural products Natural products 0.000 description 1
- 230000028017 negative regulation of cell-cell adhesion Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 108010071584 oxidized low density lipoprotein Proteins 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 239000005648 plant growth regulator Substances 0.000 description 1
- 229960003764 polydatin Drugs 0.000 description 1
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 235000020095 red wine Nutrition 0.000 description 1
- 230000014493 regulation of gene expression Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 231100000803 sterility Toxicity 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002103 transcriptional Effects 0.000 description 1
- 230000001131 transforming Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003712 vitamin E derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Abstract
The invention relates to a method for increasing flavonoid content in plants. Said method is characterized that a plant is produced using molecular genetic methods in which the activity of enzyme flavanon-3-hydroxylase is reduced.
Description
METHOD FOR PRODUCING PLANTS WITH AN ELEVATED CONTENT OF FLAVONOIDS AND PHENOLIC COMPOUNDS
The present invention relates to a method for
increase the content of flavonoids and phenolic constituents in plants, where a plant is generated, by molecular genetic methods, in which the activity of enzymatic flavanone 3-hydroxylase is reduced. Furthermore, in the method according to the invention, the activity of 3-hydroxylase of enzymatic flavanone is reduced completely or partially, permanently or temporarily, throughout the plant or in parts of the plant, by molecular biology methods ( for example antisense constructions, cosuppression, the expression of specific antibodies, or the expression of specific inhibitors). The invention also relates to plants with a high content of flavonoids and phenolic constituents, whose enzymatic activity of enzymatic flavanone 3-hydroxylase is reduced. On the other hand, the invention relates to the use of plants, generated by the method according to the invention, or parts of these plants as food products, supplements or to produce curative compositions,
compositions that promote health or tonics (juices,
a ^ w ^ - ^^. ^. a ^ L ,, ..i ^^^ - infusions, extracts, fermentation products) for humans or animals, and for the production of cosmetics. A variety of phenolic substances are found in plants, for example, caffeic acid, ferulic acid, chlorogenic acid, gallic acid, eugenol, lignans, coumarins, lignin, stilbenes (polydatin, resveratrol), flavonoids (flavones, catechins, flavanones, anthocyanidins , isoflavones), and polymethoxylated flavones. Therefore, generally also the
Phenols are generally a constituent of a number of food products and stimulants derived from plants. Certain phenolic substances are of particular importance since, after having been taken with the food, they can exert an antioxidant effect in the
human or animal metabolism (Baum, BO; Perun, AL Anti-oxidant effectiveness against structure.) Plast Engrs Trans 2: 250-257, (1962); Gardner, PT; McPhail, DB; Duthie, GG Rotational resonance spectroscopic test of electrons of antioxidant potential of teas
in aqueous and organic medium. J. Sci. Food Agrie 76: 257-262, (1997); Rice-Evans, C. A .; Miller, N. J .; Pananga, G. Relationship of antioxidant activity-structure of flavonoids and phenolic acids. Free Radie Biol. Med. 20: 933-956, (1996); Salah, N .; Miller, N. J .; Paganga, G .;
Tijburg, L .; Bol ell, G. P .; Rice-Evans, C. Flavonoides
polyphenols as an aqueous phase radical scavenger and as chain breaking antioxidants. Arch Biochem Biophys 322: 339-346, (1995); Stryer, L. Biochemistry S. Francisco: Freeman, (1975); Vieira, 0; Escargueil-Blanc, I .; Meilhac, 0; Basile, J. P .; Laranjinha, J .; Almeida, L .; Salveyre, R .; Negre-Salvayre, A. Effect of dietary phenolic compounds on apoptosis of human cultured endothelial cells induced by oxidized LDL. Br J Pharmacol 123: 565-573, (1998)). In addition, polyphenols also have a plurality of effects on cellular metabolism. Among other things, they modulate the signal transduction enzymes of protein kinase C, protein tyrosine kinase and phosphatidylinositol kinase-3.
(Agullo, G., Gamet-Payrastre, L., Manenti, S., Viala, C. Remesy, C. Chap, H., Payrastre, B. The relationship between the flavonoid structure and the inhibition of phosphatidylinositol kinase-3. : a comparison with tyrosine kinase and inhibition of protein kinase C. Biochem Pharma 53: 1649-1657, (1997), Ferriola, P. C, Cody, V. Middleton, E. Inhibition of protein kinase C by flavonoids of plant, kinetic mechanisms and structure activity relationship, Biochem Pharmacol 38: 1617-1624, (1989), Cushman, M., Nagarathman, D., Burg, DL, Geahlen, RL, Synthesis and inhibitory activity of tyrosine protein kinase. of flavonoid analogues J Meed Chem 34: 798-
^^^ - ^ t ^ - ^^ - ^ l 06, (1991); Hagi ara, W Inoue, S .; Tanaka, T .; Nunoki,
K .; Ito, M .; Hidaka, H. Differential effects of flavonoids as inhibitors of protein tyrosine kinases and serine / threonine protein kinases. Biochem Pharmacol 37: 2987-2992, (1988)) whose NO inducible synthase down regulates (Kobuchi, H., Droy-Lefaix, MT; Christen, Y .; Packer, L. Ginkgo biloba extract (EGb761): inhibitory effect on the production of nitric oxide in the macrophage cell line RAW 264.7, Biochem Pharmacol 53: 897-903, (1997)) and regulates the expression of, for example, interleukins and adhesion molecules (ICAM-1, VCAM-1)
(Kobuchi, H .: Droy-Lefaix, M. T .; Christen, Y .; Packer, L.
Ginkgo biloba extract (EGb761): inhibitory effect on the production of nitric oxide in the macrophage cell line RAW 264.7. Biochem Pharmacol 53: 897-903, (1997); Wolle, 5 J .; Hill, R. R .; Ferguson, E .; Devall, L. J .; Trivedi, B. K .; Newton, R. S.; Saxena, U. Selective inhibition of cell-cell adhesion molecule-1 gene expression induced by Tumor Necrosis Factor by a novel flavonoid. The lack of effect on transcription factor NF-kB. Atherioscler Thromb Vasc Biol 16: 1501-1508, (1996)). Now it has been accepted that these effects are beneficial to prevent heart attacks, cardiovascular diseases, diabetes, a variety of certain cancers, tumors and other chronic diseases (Bertuglia,
? a? * A ^ a aj ^^ w ^ & ^ s ^ S. ^^^^ i ^^^^ Lji S.; Malandrino, S. ¿, Colantuoni, A. Effects of natural flavonoid delphinidin on diabetic microangiopathy. Aranei-Forsch / Drug Res 45: 481-485, (1995); Griffiths, K .; Adlercreutz, H .; Boyle, P .; Denis, L .; 5 Nicholson, R.I .; Morton, M. S. Nutrition and Cancer Oxford: Isis Medical Media, (1996); Hertog, M. G. L.; Fesrens, E. J. M .; Hollman, P. C. K .; Ratan, M. B .; Kromhout, D. Flavonoids diet antioxidants and the risk of coronary heart disease: the old study of
Zutphen. The Lancet 342: 1007-1011, (1993); Kapiotis, S .; Hermann, M .; Held, I .; Seelos, C; Ehringer, H .; Gmeiner, B. M. Genistein, the angiogenesis inhibitor derived from diet, prevents the oxidation of LDL and protects the endothelial cells from atherogenic LDL damage. Arterioscler
Thromb Vasc Biol 17: 2868-74, (1997); Stampfer, M. J .; Hennekens, C. H .; Manson, J. E .; Colditz, G. A .; Roener, B .; D Willet, W. C. The consumption of vitamin E and the risk of coronary heart disease in women. New Engl J Med 328: 1444-1449, (1993); Tijburg, L. B. M .; Mattern, T.; Folts,
J. D .; Weisgerber, U. M .; Katan, M. B. Tea flavonoids and cardiovascular diseases: a review. Cpt Rev Food Sci Nutr 37: 771-785, (1997); Kirk, E. A .; Sutherland, P .; Wang, S.A .; Chait, A .; LeBoenf, R.C. Diet isoflavones reduce plasma cholesterol and
atherosclerosis in C57BL / 6 mice but not in mice
deficient LDL receptor. J Nutr 128: 954-9, (1998) -references-). A series of curative compositions, compositions that promote health or tonics whose effect is based on their content of phenolic substances that are therefore already being obtained from suitable plants (Gerritsen, ME; Carley, WW; Ranges, GE; Shen; , CP; Phan, SA; Ligon, GF; Perry, CA Flavonoids inhibit cytosine-induced endothelial cell adhesion protein gene expression Am J Pathol 147: 278-292, (1995); Lin, JK; Chen, Y C, Huang, YT, Lin-Shiau, SY suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by epigenin and curcumin J Cell Biochem Suppl 28-29: 39-48, 1997; Zi, X; Mukhtar, H.; Agarval, R. The novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: the inhibition of mRNA expression of an endogenous tumor TNF alpha promoter Biochem Biophys Res Comm 239: 334-339, 1997. Furthermore, it is known that certain food products derived from plants or stimulants prepared therefrom have a positive effect on several diseases. Resveratrol, which is found in white wine, but in particular in red wine (in addition to other components), for example, acts against heart attacks, cardiovascular diseases and cancer (Gehm, B.D.; McAndrews, J.M .; Chien, P.-Y .; Jameson, J.L. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for estrogen receptor. Proc Nati Acad Sci USA 94: 14138-14143, (1997); Jang, M .; Cai, L .; Udeam, G.O .; Slowing, K.V .; Thomas, C.F .; Beecher, C.W.W .; Fong, H.H.S; Farnsworth, N.R .; Kinghorn, A.D .; Mehtha, R.G .; Moon, R.C., Pezzuto, J.M. The cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, (1997). A similar action is also found in substances such as catechin, epicatechin-3-gallate, epigallocatechin, and epigallocatechin-3-gallate, all of which are found in tea leaves (Camellia sinensis). The drinks are made with desfermented tea leaves (green tea) in particular, they are health promoters (Hu, G., Han, Cachen, J. The inhibition of oncogene expression by green tea and (-) - epigallocatechin gallate in mice: Nutr Cancer 24: 203-209; (1995); Scholz, E; Bertram 'B .. Camellia sinensis (L.) O. Kuntze, Der Teestrauch [the tea shrubl., Z. Phytotherapie 1 7: 235-250 , (1995); Yu, R .; Jiao, JJ; Duh, JL; Gudehithlu, K .; Tan, TH; Kong, AN Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in regulation of the expression of the phase II enzyme gene mediated by the antioxidant response elements, e.Carcinigenesis 18: 451-456, (1997); Jankun, J .; Selman, SH; Swiercz, R. Green tea can prevent 1 cancer Na ture 387: 561, (1997). On the other hand, polymethoxylated flavones
of the citrus fruit also shows a potential antitumor action (Chem, J .; Montanari, AM; Widmer, Ww. Two flavanones polymethoxilierte new a class of compounds with potential anticancer activity, isolated from tangerine peel oil solids dancy cold compressed J
Agrie Food Chem 45: 364-368, (1997)). It is an object of the present invention to find a simple, inexpensive method for increasing the content of flavonoids and phenolic constituents in forage plants. It has been found that this object is achieved,
starting from the physiological studies on growth regulators of the acylcyclohexandion group, by means of genetic engineering methods, which are now available, surprisingly, and with the help of plants that can be generated, which are characterized by
a high content of healing constituents, that promote health or that tone. Acylcyclohexanediones such as prohexadione-Ca and trinexapac-ethyl (previously named: cimectacarb) are used as bioregulators to inhibit growth
longitudinal of the plants. The reason for its action
Bioregulatory is that they block the biosynthesis of gibberellins, which promote longitudinal growth. Due to their structural relationship with 2-oxobutyrate, they inhibit certain dioxygenases that require 2-oxobutaric acid as a co-substrate (Rademacher, W, Biochemical effects of plant growth retardants, in: Plant Biochemical Regulators, Gausman, HW (ed. .), Marcel Dekker, Inc., New York, pp. 169-200 (1991)). It is known that such compounds also bind in phenol metabolism and therefore are capable of causing in a variety of plant species, the production of antiocyanins that are inhibited (Rademacher, W et al., The mode of action of acylcyclohexanediones - a new type of growth retardant, in: Progress in Plant Growth Regulation, Karssen, CM, van Loon, LC, Vreugdenhil, D (eds.), Kluwer Academic Publishers, Dordrecht (1992)). Such effects on the balance of phenolic constituents are considered to be the cause for the secondary effect of prohexadione-calcium against fire blight (Rademacher, W et al., Prohexadione-Ca - a new plant growth regulator for apple with interisting biochemical features, Society of America, July 7-10, 1998, Chicago). A. Lux - Endrich (PHD Thesis, Technical University of Munich at Weihenstephan, 1998) finds in the course of its studies on the mechanism of action of prohexadione-calcium against bacterial fire, which prohexadione-calcium causes, in crops cell phones the content of phenolic substance that will increase during many occasions, during which it processes a series of phenols, which are found, which usually are not present. It was also found within these studies that prohexadione-calcium causes relatively high amounts of luteoliflavan and eriodicyol because they occur in the bud tissue of apples. Luteoliflavana does not normally occur in apple tissue, and eriodicyol occurs in small amounts only as the intermediary of flavonoid metabolism. However, the expected flavonoid catechin and cyanidin were not detected in the treated tissue, or only occurred in markedly reduced amounts (S. Rommelt et al., Paper presented at the 8 th International Worshop on Fire Blight, Kusadasi, Turkey, October 12 -15, 1998). Now it is accepted that prohexadione-Calcium, trinexapac-ethyl and other acylcyclohexandiones that inhibit the hydroxylases that depend on 2-oxoglutaric acid that play an important role in the metabolism of phenolic substances. You are mainly chalcone synthetase
(CHS) and flavanone 3-hydroxylase (F3H) (W. Heller and G.
Forkmann, Biosynthesis, in: The Flavonoids, Harborne, JB
(ed.), Chapman and Hall, New York, 1998). However, it can not be excluded that acylcyclohexanediones also inhibit other hydroxylases that depend on 2-oxoglutaric acid.
^ AA, -v.,. Go; Ap.ná ^^ wrt ^ which are not yet known. In addition, it seems obvious that a lack of catechin, cyanidin and other final products of flavannoid synthesis is recorded by the plant and that the activity of key enzyme phenylalanine ammonium lyase (PAL) is increased by a feedback mechanism. Due to the fact that CHS and F3H continue to be inhibited, however, these flavanoid end products can not be produced, and the result is an increased formation of luteoliflavan, eriodictyol and other phenols (Figure 1). Because the enzymatic activity of the enzymatic flavanone 3-hydroxylase (F3H) is reduced, the eriodictyol of flavonoids, the proanthocyanidins which are replaced on the C atom by hydrogen, for example, luteoforol, luteoliflavana, apigeniflavana and tricetiflavana, and homogeneous and heterogeneous oligomers and polymers of the aforementioned and structurally related substances are produced in larger amounts. The high concentrations of hydroxycinnamic acid of phenols (p-coumaric acid, ferulic acid, sinapic acid), salicylic acid or unbelliferone, including the homogeneous and heterogeneous oligomers and polymers formed therefrom, are found in plants after has reduced the enzyme activity of the enzymatic flavanone 3-hydroxylase (F3H).
Likewise, the concentrate of the chalcones, increases of for example, floretin, and of the stilbenes, such as, for example, resveratrol. Since enzyme activity of the enzymatic flavanone 3-hydroxylase is reduced, the concentration of the glycosides of the flavonoids, the phenolic compounds, the chalcones and the stilbenes is also increased. Starting from these findings and the hypotheses derived, the genetically modified forage plants were generated in which the activity of F3H was completely or partially reduced, permanently or temporarily, in the whole plant or in plant organisms or tissues Individuals, by means of antisense constructions, so that the content of curative, health promoting or toning substituents are improved in terms of quantity and quality. The method according to the invention for increasing the content of flavanoid and phenolic compounds by expressing flavonone 3-hydroxylase in antisense orientation can be successfully applied in the following forage plants, although the method is not restricted to the plants mentioned: vines, cherries, tomatoes, plums, sloes, blueberry, strawberries, citrus fruits (such as oranges, grapefruit), papaya, red cabbage, broccoli, brussels sprouts, cocoa, kale, carrots, parsley, celery, onions, garlic, tea, coffee, hops, soybeans, oily rape, oats, wheat, rye, Aronia melanocarpa, Ginko biloba. On the other hand, the invention relates to plants with a high content of flavonoid and phenolic constituents, generated by the method according to the invention and with a reduced enzymatic activity of the enzymatic flavanone 3-hydroxylase. As an alternative for generation plants whose flavanone 3-hydroxylase activity is reduced with the help of antisense technology, it is also possible to use other methods of molecular genetics which is known from the literature, such as cosuppression or expression. of specific antibodies, in order to achieve this effect. In addition, the invention relates to the use of plants, generated by the method according to the invention, or parts of these plants as food products, food supplements, or to produce curative compositions, health promoting compositions or tonics (juices, infusions, extracts, fermentation products) for humans and animals, and for the production of cosmetics. Surprisingly it has now been found that the plants that have been generated according to the invention, or parts of these plants or products produced therefrom (teas, extracts, fermentation products, juices and the like) have the following effects: ( 1) the antioxidant capacity in vi tro is improved (Electron Spin Resonance (ESR), LDL oxidation, total antioxidant capacity, NO elimination); (2) a modulation effect on enzymes, especially signal transduction enzymes (protein kinase C, protein tyrosine kinase, phosphatidylinositol kinase 3) is observed; (3) a modulation of redox-sensitive transcriptional factors (NF-kB, AP-1) is induced in endothelial cells, lymphocytes and soft muscle cells; (4) regulation of gene expression of target genes involved in the pathogenesis of inflammatory diseases (cytokines IL-1 and IL-8, protein 1 ma crophage chemoa ttractant (MCP-1), adhesion factors ICAM-1 is modulated and VCAM-1); (5) an antiagregatory effect is induced; (6) the synthesis of cholesterol in hepatocytes is inhibited; (7) there are antiproliferative / antineoplastic effects.
Example 1 Manipulation of a 3-hydroxylase gene from
flavanone from Lycopersicon esculentum Mill.cv. Moneymaker The ripe tomato fruits of Lycopersicon esculentum Mill.cv. Moneymaker was washed, and dried, using a sterile knife and the pericarp was freed from the seeds, the central axis and wooded parts. The pericarp (approximately 50 g) was frozen in liquid nitrogen. Then, the material was ground in a mixer. In a pre-cooled mortar, the ground material was treated with 100 ml of homogenization medium and mixed. Then, the suspension was transferred into a centrifugal flask and drained through a sterile gauze. Then, 1/10 of 10% of the volume of SDS was added and the material mixed thoroughly. After 10 minutes on ice, a volume of phenol / chloroform was added, and the centrifuge flask was sealed and the contents mixed thoroughly. After centrifugation for 15 minutes at 4000 rpm, the supernatant was transferred into a new reaction vessel. This was followed by three more phenol / chloroform extractions and one chloroform extraction. Then, 1 volume of 3 M NaAc and 2.5 volumes of ethanol were added. The nucleic acids were precipitated overnight at -20 ° C. The next morning, the nucleic acids were pelleted in a refrigerated centrifuge (4 ° C) for 15 minutes at 10,000 rpm. The supernatant was discarded and the pellet was resuspended in 5-10 ml of 3 M NaAc cold. This washing step was repeated twice. The pellet was washed with 80% ethanol. When completely dried, the pellet was extracted in approximately 0.5 ml of sterile DEPC water, and the concentration of RNA was determined photometrically. 20 μg of total RNA was first treated with 3.3 μl of 3M sodium acetate solution, 2 μl of the magnesium sulfate solution of IM, and the mixture was placed with DEPC water at a final volume of 100 μl. Added to this a
microliter of RNase-free DNase (Boehringer Mannheim), and the mixture, was incubated for 45 minutes at 37 ° C. After the enzyme has been removed by extraction with stirring with phenol / chloroform / isoamyl alcohol, the RNA was precipitated with ethanol and the pellet was extracted in 100 μl of DEPC water. 15 2.5 μg of RNA from this solution was transcribed into cDNA using a cDNA kit (Gibco BRL). Using the amino acid sequences that were derived from the cDNA clones that encode flavanone 3-hydroxylase, regions conserved in the main sequence
were identified (Britsch et al, Eur. J. Biochem 217, 745-754 (1993), and these acted as the basis for the design of the degenerate PCR oligonucleotides using the SRWPDK peptide sequence (amino acids 147- 152 in the hybrid sequence Petunia FL3H PETHY), the oligonucleotide of
5 'was determined using and had the following sequence:
'-TCI (A / C) G (A / G) TGG CC (A / C / G) GA (C / T) AA (A / G) CC-3. The sequence of the deduced oligonucleotide using the peptide sequence THQAVV (amino acid 276-281 in the hybrid sequence Petunia FL3H PETHY) was as follows: 5'-TCI (A / C) G (A / G) TGG CC (A / C / G) GA (C / T) AA (A / G) CC-3. The PCR reaction was carried out using the tTth polymerase by Perkin-Elmer following the manufacturer's instructions. 1/8 of the cDNA was used as a standard (corresponding to 0.3 μg of RNA). The PCR program was as follows: 30 cycles. 94 degrees 4 seconds 40 degrees 30 seconds 72 degrees 2 minutes 72 degrees 10 minutes The fragment was cloned into the pGEM-T vector of Promega following the manufacturer's instructions. The accuracy of the fragment was checked by sequencing. Using the Ncol and Pctl restriction cleavage sites, which are present in the vector polylinker pGEM-T, the PCR fragment was isolated, and the projections were blunted at the ends using T4 polymerase. This fragment was cloned into a pBinAR vector (blunted) Smal (Hdfgen and Willmitzer, Plant Sci 66: 221-230 (1990)) (see Figure 2). This vector contains the promoter
¿^^^^^^ you ^^ ^^^^^ you? Faith ^ te ste gjfc ^^^^^^^^^ g ^ A CaMV 35S (virus cauliflower mosaic) (Franck et al., Cell 21: 285-294 (1980)) and the octopine synthase gene termination signal (Gielen et al., EMBO J. 3: 835-846 (1984)). In plants, this vector mediates resistance to the antibiotic kanamycin 5. The resulting DNA constructs contained the PCR fragment in sense and antisense orientation.The antisense construct was used to generate transgenic plants Figure 2: Fragment A ( 529 bp) contains the
promoter 35S CaMV (nucleotide 6909 to 7437 of cauliflower mosaic virus). Fragment B contains the fragment of the F3H gene in antisense orientation. Fragment C (192 bp) contains the signal terminating the octopine synthase gene. Manipulation of a longer cDNA fragment of flavanone 3-hydroxylase from Lycopersicon esculentum Mill.cv. Moneymaker using the 5 'RACE system. To exclude the generation of plants with an amount of flow balance mRNA reduced F3H is not successful, because of the small size of the PCR fragment F3H 20 used in the construction of antisense, a second antisense construct using a fragment F3H longer must be generated. To clone a longer F3H fragment, the 5 'RACE method (system for rapid extension of cDNA ends) was used.
.aAsA.áMi »» ^ < ) & '^ Æ ia¡lfeg ^^ extension F3H PCR fragment by the method 5'RACE using the 5' RACE system for Rapid Amplification of cDNA ends, Version 2 ~ 0 by Life Technologies ™. The total mRNA was isolated from the mature tomato fruits of Lycopersicon esculentum Mili. cv. Moneymaker (see above). The first synthesis of cDNA strain was carried out following the manufacturer's instructions using GSP-1 (gene-specific primer) 5 '-TTCACCACTGCCTGGTGGTCC-3 After digestion of RNase, the cDNA was purified following the manufacturer's instructions using the system GlassMAX rotational by Life Technologies ™. Following the manufacturer's instructions, a homopolymer of cytosine was added to the 3 'end of cDNA F3H individual strain purified using deoxynucleotide transferase terminal. DNA F3H 5 'extended amplified using a second primer specific gene (GSP-2) which binds to the 5' end in the 3 'region of the recognition sequence GSP-1, and allowing it to perform this mode a "nested" PCR. The 5 'primer used was the' 5 'RACE shortened anchor primer which was provided by the manufacturer and which is complementary to the homopolymer dC termination of the cDNA. The cDNA amplified in this way, which was called F3He? Tended was cloned into the pGEM-T vector of Promega following the manufacturer's instructions. The identity of the cDNA was confirmed by sequencing. The F3Hextend? Do cDNA fragment was isolated using the restriction cut sites of Ncol and PstI, which are presented in the polylinker of the vector pGEM-T, and the projections were made blunt at the ends using T4 polymerase. This fragment was cloned into a pBinAR vector cut (blunt) (Hofgen and Willmitzer, (1990) (see Figure 3) .This vector contains the 35S CaMV promoter (cauliflower mosaic virus) (Franck et al., (1980) and the termination signal of the octopine synthase gene (Gielen et al., (1984). in plants, the average vector a resistance to antibiotic kanamycin. the constructions resulting DNA contained the PCR fragment in sense orientation and antisense The antisense construct was used to generate transgenic plants Figure 3: Fragment A (529 bp) contains the 35S CaMV promoter (nucleotides 6909 to 7437 of cauliflower mosaic virus) Fragment B contains the gene fragment F3H in antisense orientation Fragment C
(192 bp) contains the octopine synthase gene termination signal.
^^ - ^ > ^ .i? B? ^ ^^ Í Example 2 The generation of Lycopersicon esculentum Mill.cv. Transgenic moneymaker which expresses a subfragment of flavanone 3-hydroxylase in antisense orientation. The method used was that of Ling et al. , Plant Cell Report 17, 843-847 (1998). Cultivation was carried out at approximately 22 ° C under a 16-hour light / 8-hour dark regime. Tomato seeds (Lycopersicon esculentum Mill.cv. Moneymaker) were sterilized by incubation for 10 minutes in sodium hypochlorite solution at 4% strength and subsequently washed 3-4 times with sterile distilled water and placed on supplemented MS medium with 3% sucrose, pH 6.1, for germination. After a germination time of 7-10 days, the cotyledons were ready for use in the transformation. Day 1: Petri dishes containing "MSBN" medium were covered with 1.5 ml of a tobacco suspension culture of approximately 10 days. The plates were covered with film and incubated at room temperature until the next day. Days 2: Sterile filter paper was placed on the plates covered with the tobacco suspension culture in such a way that no water bubbles formed. The cotyledons, which had been cut from side to side,
They were placed on the flipped filter paper. The Petri dishes were incubated for 3 days in a culture chamber. Day 5: Agrobacterial culture (LBA4404) was sedimented for 10 minutes at approximately 3000 g and resuspended in MS medium so that the OD was 0.3. Cotyledon sections were placed inside this suspension and incubated for 30 minutes at room temperature with gentle agitation. Afterwards, the sections of cotyledons were dried a little on sterile filter paper and returned to their initial plates to continue cocultivation for 3 days in the culture chamber. Day 8: The sections of cocultivated cotyledons were placed on MSZ2K50 + ß and incubated during the following four weeks in the culture chamber. Then they were subcultured. The suckers that were formed were transferred to root induction medium. After the successful rooting, the vegetables were tested and transferred into the greenhouse. Example 3 Inhibition of cholesterol biosynthesis in cultures of primary rat epatocytes. Preparation of standard solutions
een 10 and 20 mg of the lyophilized ripe tomatoes cv. "Moneymaker" containing A) only the native flavanone 3-hydroxylase gene (control) and B) as described in Example 2, a subfragment of the flavanone 3-hydroxylase in antisense orientation, is exactly weight and was treated with such amount of DMSO that resulted in a 10 mM stock solution of total flavonoids. Immediately before the tests will begin, dilutions of these standard solutions were prepared in the culture medium. Dilution steps of these standard solutions were carried out in the culture medium. 10-fold dilution steps were carried out een 10 ~ 4 and 10 ~ 8 M. Preparation of hepatocyte cultures Primary hepatocytes were obtained from the livers of male Spraque-Dawley rats (240-290 g) by perfusion with collagenase (Gebhardt et al., Arzneimittel-Forschung / Drug Res. 41: 800-804 (1991) 1990). The hepatocytes were cultured in collagen-coated Petri dishes (6-well plates, Greiner, Nurtingen) at a cell density of 125,000 cells / cm 2 in Williams E medium supplemented with 10% calf serum. More details, in particular on the culture medium, are found in Gebhardt et al., Cell Biol. Toxicol. 6: 369-372 (1990) and Mewes et al., Cancer Res. 53: 5135-5142 (1993). After 2 hours, the cultures were transferred to a medium free of
. -. HE? Á6AA. ^.
serum supplemented with 0.1 μM insulin. After an additional 20 hours, they were used in the tests. The test substances were tested in each case in three independent cultures of 2-f3 rats. Incubation of hepatocyte cultures with test substances A and B. To demonstrate that cholesterol biosynthesis is affected by test substances A and B, hepatocyte cultures were maintained for a total of 22 hours. They were then incubated with serum-free Williams E medium supplemented with 1C acetate (trace amount only) for 2 hours together with the test substances in the indicated concentrations. In each series of tests, a control was included. The methodology is described in detail by Gebhardt (1991) and Gebhardt, Lipids 28: 613-619 (1993). The trace amounts of 14C acetate are rapidly exchanged with the intracellular acetyl-CoA pool and therefore allow the incorporation of 14C acetate into the sterol fraction, which consists of >90% cholesterol, which will be determined in a problem-free way (Gebhardt, 1993). Analytical methods to influence cholesterol biosynthesis Incorporation of 14C acetate into the sterol fraction (non-hydrolysable lipids) was inhibited by the method of Gebhardt (1991). In the extraction used, in which Extrelut® columns (Merck, Darmstadt) were used, more than 95% of 1C acetate (and small amounts of other low molecular weight metabolites formed thereof) are removed. This test allows to make comparisons between the relative speed of synthesis of cholesterol and precursor sterols under the effect of the test substances (Gebhardt, 1993). Visual and microbial quality checks of hepatocyte cultures. Before and after the test incubation, all the cultures used were visually checked under the microscope for contamination with microorganisms and for the integrity of the cell monolayer. A recognizable change in cell morphology (particularly at high concentrations) was not observed in any of the samples. This largely excludes that the results of the test were affected by cytotoxic effects of the test substances. The tests of routine sterility on all crops revealed no signs of contamination with microorganisms. Results Samples A) of the tomatoes that were not genetically modified (control) showed no effect on cholesterol biosynthesis. In contrast, cholesterol synthesis was significantly inhibited by B samples
tagM i .. ».
of tomatoes containing a subfragment of flavanone 3-hydroxylase in antisense orientation. ^, ^ ¡^ ¿? T fe ^ ¿A ^ A ^.,
Claims (5)
- CLAIMS 1. A method to increase the content of flavonoids and phenolic constituents in plants, where a plant is generated, by molecular genetic methods in which the activity of the enzymatic flavanone 3-hydroxylase is reduced.
- 2. A method as claimed in claim 1 for increasing the content of flavonoids and phenolic constituents in plants, wherein the activity of the 3-hydroxylase of enzymatic flavanone is reduced completely or partially, permanently, or temporarily, throughout the plant or parts of the plant by molecular biology methods (eg, antisense constructs, or deletion, expression of specific antibodies or the expression of specific inhibitors).
- 3. A method as claimed in claim 1 or 2, wherein the plants are vines, cherries, tomatoes, plums, sloes, blueberry, strawberries, citrus fruits, (such as oranges, grapefruit), papaya, red cabbage, broccoli, brussels sprouts, cacao, kale, carrots, parsley, celery, onions, garlic, tea, coffee, hops, soybeans, oleaginasa, oats, wheat, rye, Aronia melanocarpa, Ginkgo biloba.
- 4. A plant with a high content of flavonoids and phenolic constituents generated by a method as claimed in any of claims 1-3, wherein the enzymatic activity of the enzymatic flavanone 3-hydroxylase is reduced.
- 5. The use of plant or parts of these plants, generated by a method as claimed in any of claims 1-3, as food products, supplements, or to produce curative compositions, health promoting compositions or tonics ( juices, teas, extracts, fermentation products) for humans and animals, and for the production of cosmetics. • «^
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19927574.2 | 1999-06-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA01001609A true MXPA01001609A (en) | 2001-11-21 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lange et al. | Metabolic engineering of plant monoterpenes, sesquiterpenes and diterpenes—current status and future opportunities | |
Misra et al. | Modulation of transcriptome and metabolome of tobacco by Arabidopsis transcription factor, AtMYB12, leads to insect resistance | |
Karppinen et al. | Changes in the abscisic acid levels and related gene expression during fruit development and ripening in bilberry (Vaccinium myrtillus L.) | |
Pandey et al. | Development of AtMYB12-expressing transgenic tobacco callus culture for production of rutin with biopesticidal potential | |
Espley et al. | Red to brown: an elevated anthocyanic response in apple drives ethylene to advance maturity and fruit flesh browning | |
KR100697738B1 (en) | Method of Increasing the Content of Flavonoids and Phenolic Substances in Plants | |
Baldi et al. | Gene expression and metabolite accumulation during strawberry (Fragaria× ananassa) fruit development and ripening | |
Gutensohn et al. | Metabolic engineering of monoterpene biosynthesis in tomato fruits via introduction of the non-canonical substrate neryl diphosphate | |
Boba et al. | Methyl salicylate level increase in flax after Fusarium oxysporum infection is associated with phenylpropanoid pathway activation | |
CA2340319A1 (en) | Method for producing plants with increased flavonoid and phenolic compound content | |
Hutabarat et al. | Transgenic apple plants overexpressing the chalcone 3-hydroxylase gene of Cosmos sulphureus show increased levels of 3-hydroxyphloridzin and reduced susceptibility to apple scab and fire blight | |
Pandey et al. | Over-expression of mouse ornithine decarboxylase gene under the control of fruit-specific promoter enhances fruit quality in tomato | |
Zheng et al. | Brassinosteroid regulates 3-hydroxy-3-methylglutaryl CoA reductase to promote grape fruit development | |
Colliver et al. | Improving the nutritional content of tomatoes through reprogramming their flavonoid biosynthetic pathway | |
Corbin et al. | Identification and characterization of cis-acting elements involved in the regulation of ABA-and/or GA-mediated LuPLR1 gene expression and lignan biosynthesis in flax (Linum usitatissimum L.) cell cultures | |
Siebeneichler et al. | Changes in the abscisic acid, phenylpropanoids and ascorbic acid metabolism during strawberry fruit growth and ripening | |
Madhulatha et al. | Fruit-specific over-expression of human S-adenosylmethionine decarboxylase gene results in polyamine accumulation and affects diverse aspects of tomato fruit development and quality | |
Castrillón-Arbeláez et al. | Secondary metabolism in Amaranthus spp.—a genomic approach to understand its diversity and responsiveness to stress in marginally studied crops with high agronomic potential | |
Norton et al. | Characterisation of recombinant Hevea brasiliensis allene oxide synthase: effects of cycloxygenase inhibitors, lipoxygenase inhibitors and salicylates on enzyme activity | |
US20110283424A1 (en) | Gene Encoding Lignan Methylation Enzyme | |
MXPA01001609A (en) | Method for producing plants with increased flavonoid and phenolic compound content | |
US20240147927A1 (en) | Methods of high production of polyphenols from red lettuces and uses thereof | |
Tissier | Harnessing plant trichome biochemistry for the production of useful compounds | |
Sun et al. | Molecular cloning and characterization of three isoprenyl diphosphate synthase genes from alfalfa | |
Sanimah et al. | Identification of phytochemicals and the associated genes in Eksotika papaya at ripening index 5 using functional genomics. |